RNTX
Rein Therapeutics
RNTX
RNTX
19 hedge funds and large institutions have $3.21M invested in Rein Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
45% less capital invested
Capital invested by funds: $5.86M → $3.21M (-$2.64M)
87% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 15
Holders
19
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$15.5K | |
| 2 | +$7.61K | |
| 3 | +$5K | |
| 4 |
Renaissance Technologies
New York
|
+$2.44K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$820 |
Top Sellers
| 1 | -$62.7K | |
| 2 | -$38K | |
| 3 | -$24.3K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$24K |
| 5 |
State Street
Boston,
Massachusetts
|
-$21K |